Pharmacologic management of cancer-related pain, dyspnea, and nausea

Seminars in Oncology

Volumn 38, Issue 3, 2011, Pages 450-459

  Cheung, Winson Y ^a   Zimmermann, Camilla ^b  

^a BRITISH COLUMBIA CANCER AGENCY   (Canada)

^b PRINCESS MARGARET HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BEVACIZUMAB; BISPHOSPHONIC ACID DERIVATIVE; CISPLATIN; CODEINE; CYCLIZINE; CYCLOPHOSPHAMIDE; DESIPRAMINE; DOXORUBICIN; DULOXETINE; EPIRUBICIN; ETOPOSIDE; FUROSEMIDE; GABAPENTIN; GEMCITABINE; HALOPERIDOL; HYDROMORPHONE; LEVOMEPROMAZINE; LIDOCAINE; METHADONE; MORPHINE; NORTRIPTYLINE; OXYCODONE; PARACETAMOL; PREGABALIN; TRAMADOL; VENLAFAXINE;

ABDOMINAL PAIN; ADVANCED CANCER; ANALGESIA; ANOREXIA; BACKACHE; BONE PAIN; CANCER PAIN; CANCER PATIENT; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL PRACTICE; CONFERENCE PAPER; CONFUSION; CONSTIPATION; DROWSINESS; DRUG DOSE INCREASE; DRUG DOSE TITRATION; DRUG EFFECT; DRUG SAFETY; DRUG TOLERABILITY; DYSPNEA; FATIGUE; FRACTURE; HALLUCINATION; HEADACHE; HUMAN; HYPERANALGESIA; IMPOTENCE; JAW OSTEONECROSIS; MYOCLONUS; NAUSEA; NAUSEA AND VOMITING; NEUROPATHIC PAIN; ORTHOSTATIC HYPOTENSION; OXYGEN THERAPY; PALLIATIVE THERAPY; PATIENT COMPLIANCE; PERIPHERAL EDEMA; PRIORITY JOURNAL; PRURITUS; RESPIRATION DEPRESSION; SEDATION; SIDE EFFECT; SPINAL CORD COMPRESSION; STOMACH PARESIS; SWEATING; URINE RETENTION; VOMITING; XEROSTOMIA;

ANALGESICS; ANTIEMETICS; DYSPNEA; HUMANS; NAUSEA; NEOPLASMS; PAIN; PALLIATIVE CARE;

EID: 79956201189     PISSN: 00937754     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.seminoncol.2011.03.016     Document Type: Conference Paper

References (86)

1. W.Y. Cheung, N. Barmala, and S. Zarinehbaf The association of physical and psychological symptom burden with time to death among palliative cancer outpatients J Pain Symptom Manage 37 2009 297 304
2. S.C. Teunissen, W. Wesker, and C. Kruitwagen Symptom prevalence in patients with incurable cancer: a systematic review J Pain Symptom Manage 34 2007 94 104 (Pubitemid 46970881)
3. A. Yamagishi, T. Morita, and M. Miyashita Symptom prevalence and longitudinal follow-up in cancer outpatients receiving chemotherapy J Pain Symptom Manage 37 2009 823 830
4. W.Y. Cheung, L.W. Le, and C. Zimmermann Symptom clusters in patients with advanced cancers Support Care Cancer 17 2009 1223 1230
5. W.Y. Cheung, L.W. Le, and L. Gagliese Age and gender differences in symptom intensity and symptom clusters among patients with metastatic cancer Support Care Cancer 19 2011 417 423
6. T. Borneman, M. Koczywas, and M. Cristea An interdisciplinary care approach for integration of palliative care in lung cancer Clin Lung Cancer 9 2008 352 360
7. L.C. Goudas, R. Bloch, and M. Gialeli-Goudas The epidemiology of cancer pain Cancer Invest 23 2005 182 190 (Pubitemid 40463916)
8. C. Zaza, and N. Baine Cancer pain and psychosocial factors: a critical review of the literature J Pain Symptom Manage 24 2002 526 542 (Pubitemid 36120428)
9. M.S. Jordhoy, P. Fayers, and J.H. Loge Quality of life in advanced cancer patients: the impact of sociodemographic and medical characteristics Br J Cancer 85 2001 1478 1485 (Pubitemid 34001577)
10. P.J. Christo, and D. Mazloomdoost Cancer pain and analgesia Ann N Y Acad Sci 1138 2008 278 298
11. A. Caraceni, and R.K. Portenoy An international survey of cancer pain characteristics and syndromes IASP task force on cancer pain. international association for the study of pain Pain 82 1999 263 274
12. G. Rodin, C. Lo, and M. Mikulincer Pathways to distress: the multiple determinants of depression, hopelessness, and the desire for hastened death in metastatic cancer patients Soc Sci Med 68 2009 562 569
13. D. Spiegel, S. Sands, and C. Koopman Pain and depression in patients with cancer Cancer 74 1994 2570 2578 (Pubitemid 24320864)
14. P.J. Hoskin Radioisotopes for metastatic bone pain Lancet Oncol 6 2005 353 354 (Pubitemid 40753722)
15. C.A. Cullinane, D.Z. Chu, and A.N. Mamelak Current surgical options in the control of cancer pain Cancer Pract 10 Suppl 1 2002 S21 S26
16. A.R. Jadad, and G.P. Browman The WHO analgesic ladder for cancer pain management Stepping up the quality of its evaluation JAMA 274 1995 1870 1873 (Pubitemid 26001265)
17. S.H. Snyder, and G.W. Pasternak Historical review: opioid receptors Trends Pharmacol Sci 24 2003 198 205 (Pubitemid 36432108)
18. S.H. Snyder Opiate receptor revisited Anesthesiology 107 2007 659 661
19. V. Launay-Vacher, S. Karie, and J.B. Fau Treatment of pain in patients with renal insufficiency: the World Health Organization three-step ladder adapted J Pain 6 2005 137 148 (Pubitemid 40365017)
20. P. Niscola, L. Scaramucci, and G. Vischini The use of major analgesics in patients with renal dysfunction Curr Drug Targets 11 2010 752 758
21. S.N. Davison, and P.R. Mayo Pain management in chronic kidney disease: the pharmacokinetics and pharmacodynamics of hydromorphone and hydromorphone-3-glucuronide in hemodialysis patients J Opioid Manag 4 2008 335 336 339-44
22. H.A. Parsons, M. de la Cruz, and B. El Osta Methadone initiation and rotation in the outpatient setting for patients with cancer pain Cancer 116 2010 520 528
23. J. Bryson, A. Tamber, and D. Seccareccia Methadone for treatment of cancer pain Curr Oncol Rep 8 2006 282 288 (Pubitemid 43970979)
24. R. Chou, E. Clark, and M. Helfand Comparative efficacy and safety of long-acting oral opioids for chronic non-cancer pain: a systematic review J Pain Symptom Manage 26 2003 1026 1048 (Pubitemid 37324684)
25. E. Bruera, J.L. Palmer, and S. Bosnjak Methadone versus morphine as a first-line strong opioid for cancer pain: a randomized, double-blind study J Clin Oncol 22 2004 185 192 (Pubitemid 41095131)
26. G. Zeppetella Impact and management of breakthrough pain in cancer Curr Opin Support Palliat Care 3 2009 1 6
27. D. Tassinari, S. Sartori, and E. Tamburini Transdermal fentanyl as a front-line approach to moderate-severe pain: a meta-analysis of randomized clinical trials J Palliat Care 25 2009 172 180
28. P.H. Coluzzi, L. Schwartzberg, and J.D. Conroy Breakthrough cancer pain: a randomized trial comparing oral transmucosal fentanyl citrate (OTFC) and morphine sulfate immediate release (MSIR) Pain 91 2001 123 130 (Pubitemid 32274181)
29. S. Mercadante, L. Radbruch, and A. Davies A comparison of intranasal fentanyl spray with oral transmucosal fentanyl citrate for the treatment of breakthrough cancer pain: an open-label, randomised, crossover trial Curr Med Res Opin 25 2009 2805 2815
30. E. Eisenberg, C.S. Berkey, and D.B. Carr Efficacy and safety of nonsteroidal antiinflammatory drugs for cancer pain: a meta-analysis J Clin Oncol 12 1994 2756 2765 (Pubitemid 24379666)
31. E. McNicol, S.A. Strassels, and L. Goudas NSAIDS or paracetamol, alone or combined with opioids, for cancer pain Cochrane Database Syst Rev 1 2005 CD005180
32. E. Marret, O. Kurdi, and P. Zufferey Effects of nonsteroidal antiinflammatory drugs on patient-controlled analgesia morphine side effects: meta-analysis of randomized controlled trials Anesthesiology 102 2005 1249 1260 (Pubitemid 40745845)
33. D. Lussier, A.G. Huskey, and R.K. Portenoy Adjuvant analgesics in cancer pain management Oncologist 9 2004 571 591 (Pubitemid 39332322)
34. R.H. Dworkin, A.B. O'Connor, and M. Backonja Pharmacologic management of neuropathic pain: evidence-based recommendations Pain 132 2007 237 251 (Pubitemid 350051570)
35. A.B. O'Connor, and R.H. Dworkin Treatment of neuropathic pain: an overview of recent guidelines Am J Med 122 2009 S22 S32
36. D.E. Moulin, A.J. Clark, and I. Gilron Pharmacological management of chronic neuropathic painconsensus statement and guidelines from the Canadian Pain Society Pain Res Manag 12 2007 13 21 (Pubitemid 46744774)
37. I. Gilron, J.M. Bailey, and D. Tu Morphine, gabapentin, or their combination for neuropathic pain N Engl J Med 352 2005 1324 1334 (Pubitemid 40411499)
38. R.H. Dworkin, M. Backonja, and M.C. Rowbotham Advances in neuropathic pain: diagnosis, mechanisms, and treatment recommendations Arch Neurol 60 2003 1524 1534 (Pubitemid 37443116)
39. I. Gilron, J.M. Bailey, and D. Tu Nortriptyline and gabapentin, alone and in combination for neuropathic pain: a double-blind, randomised controlled crossover trial Lancet 374 2009 1252 1261
40. M. Aapro, P.A. Abrahamsson, and J.J. Body Guidance on the use of bisphosphonates in solid tumours: recommendations of an international expert panel Ann Oncol 19 2008 420 432
41. J.R. Gralow, J.S. Biermann, and A. Farooki NCCN task force report: bone health in cancer care J Natl Compr Canc Netw 7 Suppl 3 2009 S1 S32
42. O. Filleul, E. Crompot, and S. Saussez Bisphosphonate-induced osteonecrosis of the jaw: a review of 2,400 patient cases J Cancer Res Clin Oncol 136 2010 1117 1124
43. S.L. Mercadante, M. Berchovich, and A. Casuccio A prospective randomized study of corticosteroids as adjuvant drugs to opioids in advanced cancer patients Am J Hosp Palliat Care 24 2007 13 19
44. A. Shih, and K.C. Jackson 2nd Role of corticosteroids in palliative care J Pain Palliat Care Pharmacother 21 2007 69 76 (Pubitemid 47585225)
45. C. Ripamonti, and E. Bruera Dyspnea: pathophysiology and assessment J Pain Symptom Manage 13 1997 220 232 (Pubitemid 27200985)
46. C. Ripamonti, F. Fulfaro, and E. Bruera Dyspnoea in patients with advanced cancer: Incidence, causes and treatments Cancer Treat Rev 24 1998 69 80 (Pubitemid 28200876)
47. I. Ben-Aharon, A. Gafter-Gvili, and M. Paul Interventions for alleviating cancer-related dyspnea: a systematic review J Clin Oncol 26 2008 2396 2404
48. E. Bruera, N. de Stoutz, and A. Velasco-Leiva Effects of oxygen on dyspnoea in hypoxaemic terminal-cancer patients Lancet 342 1993 13 14 (Pubitemid 23183914)
49. H.E. Uronis, D.C. Currow, and D.C. McCrory Oxygen for relief of dyspnoea in mildly- or non-hypoxaemic patients with cancer: a systematic review and meta-analysis Br J Cancer 98 2008 294 299 (Pubitemid 351161251)
50. A.P. Abernethy, C.F. McDonald, and P.A. Frith Effect of palliative oxygen versus room air in relief of breathlessness in patients with refractory dyspnoea: a double-blind, randomised controlled trial Lancet 376 2010 784 793
51. J.R. Thomas, and C.F. von Gunten Management of dyspnea J Support Oncol 1 2003 23 32
52. J.R. Thomas, and C.F. von Gunten Clinical management of dyspnoea Lancet Oncol 3 2002 223 228 (Pubitemid 34436658)
53. R.M. Schwartzstein, K. Lahive, and A. Pope Cold facial stimulation reduces breathlessness induced in normal subjects Am Rev Respir Dis 136 1987 58 61 (Pubitemid 18026433)
54. A. Qaseem, V. Snow, and P. Shekelle Evidence-based interventions to improve the palliative care of pain, dyspnea, and depression at the end of life: a clinical practice guideline from the american college of physicians Ann Intern Med 148 2008 141 146 (Pubitemid 351651556)
55. A.P. Abernethy, D.C. Currow, and P. Frith Randomised, double blind, placebo controlled crossover trial of sustained release morphine for the management of refractory dyspnoea BMJ 327 2003 523 528
56. P. Allard, C. Lamontagne, and P. Bernard How effective are supplementary doses of opioids for dyspnea in terminally ill cancer patients? A randomized continuous sequential clinical trial J Pain Symptom Manage 17 1999 256 265 (Pubitemid 29159968)
57. C. Mazzocato, T. Buclin, and C.H. Rapin The effects of morphine on dyspnea and ventilatory function in elderly patients with advanced cancer: a randomized double-blind controlled trial Ann Oncol 10 1999 1511 1514 (Pubitemid 30017064)
58. K.E. Clemens, and E. Klaschik Symptomatic therapy of dyspnea with strong opioids and its effect on ventilation in palliative care patients J Pain Symptom Manage 33 2007 473 481 (Pubitemid 46482946)
59. K.E. Clemens, I. Quednau, and E. Klaschik Is there a higher risk of respiratory depression in opioid-naive palliative care patients during symptomatic therapy of dyspnea with strong opioids? J Palliat Med 11 2008 204 216 (Pubitemid 351374202)
60. R. Viola, C. Kiteley, and N.S. Lloyd The management of dyspnea in cancer patients: a systematic review Support Care Cancer 16 2008 329 337
61. P.J. Coyne, R. Viswanathan, and T.J. Smith Nebulized fentanyl citrate improves patients' perception of breathing, respiratory rate, and oxygen saturation in dyspnea J Pain Symptom Manage 23 2002 157 160 (Pubitemid 34158649)
62. S.J. Brown, S.F. Eichner, and J.R. Jones Nebulized morphine for relief of dyspnea due to chronic lung disease Ann Pharmacother 39 2005 1088 1092 (Pubitemid 40695977)
63. E. Bruera, R. Sala, and O. Spruyt Nebulized versus subcutaneous morphine for patients with cancer dyspnea: a preliminary study J Pain Symptom Manage 29 2005 613 618 (Pubitemid 40826484)
64. J. Congleton, and M.F. Muers The incidence of airflow obstruction in bronchial carcinoma, its relation to breathlessness, and response to bronchodilator therapy Respir Med 89 1995 291 296
65. S.T. Simon, I.J. Higginson, and S. Booth Benzodiazepines for the relief of breathlessness in advanced malignant and non-malignant diseases in adults Cochrane Database Syst Rev 1 2010 CD007354
66. A.H. Navigante, L.C. Cerchietti, and M.A. Castro Midazolam as adjunct therapy to morphine in the alleviation of severe dyspnea perception in patients with advanced cancer J Pain Symptom Manage 31 2006 38 47 (Pubitemid 43143297)
67. P.J. Newton, P.M. Davidson, and P. Macdonald Nebulized furosemide for the management of dyspnea: does the evidence support its use? J Pain Symptom Manage 36 2008 424 441
68. J.E. Groopman, and L.M. Itri Chemotherapy-induced anemia in adults: incidence and treatment J Natl Cancer Inst 91 1999 1616 1634 (Pubitemid 29479929)
69. M.F. Murphy, T.B. Wallington, and P. Kelsey Guidelines for the clinical use of red cell transfusions Br J Haematol 113 2001 24 31 (Pubitemid 32423296)
70. J. Bohlius, J. Wilson, and J. Seidenfeld Erythropoietin or darbepoetin for patients with cancer Cochrane Database Syst Rev 3 2006 CD003407
71. J. Bohlius, J. Wilson, and J. Seidenfeld Recombinant human erythropoietins and cancer patients: updated meta-analysis of 57 studies including 9353 patients J Natl Cancer Inst 98 2006 708 714 (Pubitemid 43821788)
72. M.P. Davis, and G. Hallerberg Palliative Medicine Study Group of the Multinational Association of Supportive Care in Cancer A systematic review of the treatment of nausea and/or vomiting in cancer unrelated to chemotherapy or radiation J Pain Symptom Manage 39 2010 756 767
73. A. Haiderali, L. Menditto, and M. Good Impact on daily functioning and indirect/direct costs associated with chemotherapy-induced nausea and vomiting (CINV) in a US population Support Care Cancer 2010 June 9 [Epub ahead of print]
74. D.G. Frame Best practice management of CINV in oncology patients: I Physiology and treatment of CINV. multiple neurotransmitters and receptors and the need for combination therapeutic approaches J Support Oncol 8 2010 5 9
75. F. Roila, J. Herrstedt, and M. Aapro Guideline update for MASCC and ESMO in the prevention of chemotherapy- and radiotherapy-induced nausea and vomiting: results of the perugia consensus conference Ann Oncol 21 Suppl 5 2010 v232 v243
76. P.V. Tortorice, and M.B. O'Connell Management of chemotherapy-induced nausea and vomiting Pharmacotherapy 10 1990 129 145 (Pubitemid 20149607)
77. M.G. Kris, P.J. Hesketh American Society of Clinical Oncology American Society of Clinical Oncology guideline for antiemetics in oncology: update 2006 J Clin Oncol 24 2006 2932 2947 (Pubitemid 46630595)
78. J.M. Koeller, M.S. Aapro, and R.J. Gralla Antiemetic guidelines: creating a more practical treatment approach Support Care Cancer 10 2002 519 522 (Pubitemid 36061646)
79. J. Herrstedt, H.B. Muss, and D.G. Warr Efficacy and tolerability of aprepitant for the prevention of chemotherapy-induced nausea and emesis over multiple cycles of moderately emetogenic chemotherapy Cancer 104 2005 1548 1555 (Pubitemid 41356171)
80. C. Figueroa-Moseley, P. Jean-Pierre, and J.A. Roscoe Behavioral interventions in treating anticipatory nausea and vomiting J Natl Compr Cancer Netw 5 2007 44 50 (Pubitemid 46212276)
81. R. Zachariae, K. Paulsen, and M. Mehlsen Anticipatory nausea: the role of individual differences related to sensory perception and autonomic reactivity Ann Behav Med 33 2007 69 79
82. S.J. Panchal, P. Muller-Schwefe, and J.I. Wurzelmann Opioid-induced bowel dysfunction: Prevalence, pathophysiology and burden Int J Clin Pract 61 2007 1181 1187 (Pubitemid 46934629)
83. P. Glare, G. Pereira, and L.J. Kristjanson Systematic review of the efficacy of antiemetics in the treatment of nausea in patients with far-advanced cancer Support Care Cancer 12 2004 432 440 (Pubitemid 38797099)
84. M. Pappagallo Incidence, prevalence, and management of opioid bowel dysfunction Am J Surg 182 2001 11S 18S (Pubitemid 34072942)
85. A.R. Gammaitoni, P. Fine, and N. Alvarez Clinical application of opioid equianalgesic data Clin J Pain 19 2003 286 297 (Pubitemid 37080576)
86. J. Pereira, P. Lawlor, and A. Vigano Equianalgesic dose ratios for opioids. a critical review and proposals for long-term dosing J Pain Symptom Manage 22 2001 672 687 (Pubitemid 32725810)